Clinical Trials Arena - News and Views Updated Daily

Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Impel doses first subject in Phase l trial of INP105

Impel NeuroPharma has dosed the first subject in the Phase l Safety and Tolerability of...
Read More...

Impel doses first subject in Phase l trial of INP105

Supporting mental health in a business environment

Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report